Pharmacoeconomic considerations in the treatment of multiple sclerosis.

Pharmacoeconomic considerations in the treatment of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37781806
Cost-Effectiveness of Disease-Modifying Therapies in Multiple SclerosisNatalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis.Cost of Illness of Multiple Sclerosis - A Systematic Review.Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.There is much to be learnt about the costs of multiple sclerosis in Latin America.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Disease-modifying therapies in multiple sclerosis in Latin AmericaRetrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study.Cost of multiple sclerosis in the Czech Republic: the COMS study.ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom
P2860

Pharmacoeconomic considerations in the treatment of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37781806
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@en
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@nl
type
label
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@en
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@nl
prefLabel
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@en
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Pharmacoeconomic considerations in the treatment of multiple sclerosis.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11538000-000000000-00000
P433
P478
P50
P577
P6179
P698
P921